Tumorablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of High-Risk and Refractory Leukemia — New Concepts and Clinical Practice

None

Guardado en:
Detalles Bibliográficos
Autores principales: Da, Wan-ming, Da, Yong
Formato: Capítulo de libro
Lenguaje:inglés
Publicado: IntechOpen 2013
Materias:
Acceso en línea:https://www.intechopen.com/chapters/42607
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1879225206841540609
author Da, Wan-ming
Da, Yong
author_browse Da, Wan-ming
Da, Yong
author_facet Da, Wan-ming
Da, Yong
author_sort Da, Wan-ming
building IntechOpen
collection Acceso abierto
description None
doi_str_mv 10.5772/53031
first_indexed 2026-10-16T13:40:13Z
format Book Chapter
fullrecord <oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><identifier>intech-42607</identifier><datestamp>2013-02-13</datestamp> <dc:title>Tumorablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of High-Risk and Refractory Leukemia — New Concepts and Clinical Practice</dc:title> <dc:creator>Wan-ming Da</dc:creator> <dc:creator>Yong Da</dc:creator> <dc:subject>Health Sciences</dc:subject> <dc:description>None</dc:description> <dc:publisher>IntechOpen</dc:publisher> <dc:date>2013-02-13</dc:date> <dc:type>Chapter, Part Of Book</dc:type> <dc:identifier>https://www.intechopen.com/chapters/42607</dc:identifier> <dc:identifier>doi:10.5772/53031</dc:identifier> <dc:language>en</dc:language> <dc:relation>ISBN:978-953-51-0980-8</dc:relation> <dc:rights>https://creativecommons.org/licenses/by/3.0/</dc:rights> <dc:source>https://www.intechopen.com/books/3458 ; Innovations in Stem Cell Transplantation</dc:source> </oai_dc:dc>
id intech-42607
institution IntechOpen
isbn 978-953-51-0980-8
language English
last_indexed 2026-10-16T13:40:13Z
publishDate 2013
publishDateRange 2013
publishDateSort 2013
publisher IntechOpen
publisherStr IntechOpen
record_format oai_dc
spelling intech-426072013-02-13 Tumorablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of High-Risk and Refractory Leukemia — New Concepts and Clinical Practice Wan-ming Da Yong Da Health Sciences None IntechOpen 2013-02-13 Chapter, Part Of Book https://www.intechopen.com/chapters/42607 doi:10.5772/53031 en ISBN:978-953-51-0980-8 https://creativecommons.org/licenses/by/3.0/ https://www.intechopen.com/books/3458 ; Innovations in Stem Cell Transplantation
spellingShingle Health Sciences
Da, Wan-ming
Da, Yong
Tumorablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of High-Risk and Refractory Leukemia — New Concepts and Clinical Practice
title Tumorablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of High-Risk and Refractory Leukemia — New Concepts and Clinical Practice
title_full Tumorablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of High-Risk and Refractory Leukemia — New Concepts and Clinical Practice
title_fullStr Tumorablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of High-Risk and Refractory Leukemia — New Concepts and Clinical Practice
title_full_unstemmed Tumorablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of High-Risk and Refractory Leukemia — New Concepts and Clinical Practice
title_short Tumorablative Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of High-Risk and Refractory Leukemia — New Concepts and Clinical Practice
title_sort tumorablative allogeneic hematopoietic stem cell transplantation in the treatment of high risk and refractory leukemia new concepts and clinical practice
topic Health Sciences
url https://www.intechopen.com/chapters/42607
work_keys_str_mv AT dawanming tumorablativeallogeneichematopoieticstemcelltransplantationinthetreatmentofhighriskandrefractoryleukemianewconceptsandclinicalpractice
AT dayong tumorablativeallogeneichematopoieticstemcelltransplantationinthetreatmentofhighriskandrefractoryleukemianewconceptsandclinicalpractice